vitamin k 3 has been researched along with Cystic Fibrosis in 5 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, WJ | 1 |
| Goeckeler-Fried, JL | 1 |
| Havasi, V | 1 |
| Chiang, A | 1 |
| Rowe, SM | 1 |
| Plyler, ZE | 1 |
| Hong, JS | 1 |
| Mazur, M | 1 |
| Piazza, GA | 1 |
| Keeton, AB | 1 |
| White, EL | 1 |
| Rasmussen, L | 1 |
| Weissman, AM | 1 |
| Denny, RA | 1 |
| Brodsky, JL | 1 |
| Sorscher, EJ | 1 |
| de Souza, DC | 1 |
| Cogo, LL | 1 |
| Palmeiro, JK | 1 |
| Dalla-Costa, LM | 1 |
| de Oliveira Tomaz, AP | 1 |
| Riedi, CA | 1 |
| Rosario Filho, NA | 1 |
| Staerck, C | 1 |
| Godon, C | 1 |
| Bouchara, JP | 1 |
| Fleury, MJJ | 1 |
| Delgado-Valverde, M | 1 |
| Fernández-Echauri, P | 1 |
| Batista-Díaz, N | 1 |
| Pascual-Hernández, A | 1 |
| Huyghebaert, N | 1 |
| De Beer, J | 1 |
| Vervaet, C | 1 |
| Remon, JP | 1 |
5 other studies available for vitamin k 3 and Cystic Fibrosis
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regu | 2016 |
Thymidine-auxotrophic Staphylococcus aureus small-colony variant bacteremia in a patient with cystic fibrosis.
Topics: Anti-Bacterial Agents; Bacteremia; Cystic Fibrosis; Drug Resistance, Bacterial; Genes, Bacterial; Ge | 2020 |
Varying susceptibility of clinical and environmental Scedosporium isolates to chemical oxidative stress in conidial germination.
Topics: Cystic Fibrosis; Humans; Oxidants; Oxidative Stress; Paraquat; Reactive Oxygen Species; Scedosporium | 2018 |
[Small-colony variants of Staphylococcus aureus: Usefulness of various test for diagnosis and susceptibility study].
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Clone Cells; Colony Count, Microbial; Culture Med | 2014 |
Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study.
Topics: Capsules; Cholecalciferol; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Combinations; | 2007 |